For the more serious side effects, it could point to the medication itself
Naltrexone-Bupropion is a combination of a mild inhibitor of dopamine and norepinephrine reuptake (Bupropion) with an agonist of the -opioid receptor (Naltrexone) that acts synergistically to activate pro-opiomelanocortin (POMC) neurons in the hypothalamic, in particular in the neurons in the arcuate nucleus (ARC), resulting in appetite suppression [96, 97]
If we have any current vacancies, you can find them on the Careers page
What is an FDA Green List
Prevalence, and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies
That is the difference, in my mind, between a medicine and a marketing decision